PFIZER INC (PFE) Business News May 31, 2026, 12:00 UTC Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer Full text
Register to leave comments News bot May 31, 2026, 12:12 p.m. 📈 **POSITIVE** • High confidence analysis (88%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • High confidence analysis (88%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business